Conflicts of Interest and Disclosures in Publications

Clinical Gastroenterology and Hepatology

Volumn 5, Issue 3, 2007, Pages

  Camilleri, Michael ^a   Dubnansky, Erin C ^a   Rustgi, Anil K ^a  

^a AGA Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFLICT OF INTEREST; EDITOR; FINANCIAL MANAGEMENT; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL PROFESSION; MEDICAL SOCIETY; PRACTICE GUIDELINE; PROFESSIONAL MISCONDUCT; PUBLICATION;

EID: 33947134859     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.12.031     Document Type: Article

References (16)

1. McNeil DG. Tough-talking editor faces accusation of leniency. The New York Times, August 1, 2006. Available at: http://www.nytimes.com/2006/08/01/science/01prof.html. Accessed August 5, 2006.
2. Cohen JJ. A word from the president: let's look a gift horse in the mouth. Reporter. Vol 10. Available at: http://www.aamc.org/newsroom/reporter/june01/word.htm. Accessed August 25, 2006.
3. Brennan T.A., Rothman D.J., Blank L., et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 25; (2006) 295 429-433
4. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication. 2005. Section II D. Conflicts of Interest. Available at: http://www.icmje.org. Accessed January 25, 2007.
5. Angell M., and Kassirer J.P. Editorials and conflicts of interest. N Engl J Med 335 (1996) 1055-1056
6. Davidoff F., DeAngelis C.D., Drazen J.M., et al. Sponsorship, authorship, and accountability. JAMA 286 (2001) 1232-1234
7. Drazen J.M., and Curfman G.D. Financial associations of authors. N Engl J Med 346 (2002) 1901-1902
8. DeAngelis C.D., Fontanarosa P.B., and Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA 286 (2001) 89-91
9. Instructions for authors. JAMA 294 (2005) 119-125
10. Flanagin A., Fontanarosa P.B., and DeAngelis C.D. Update on JAMA's conflict of interest policy. JAMA 296 (2006) 220-221
11. Armstrong, David. "Bitter pill: how the New England Journal missed warning signs on Vioxx: medical weekly waited years to report flaws in article that praised pain drug-Merck seen as 'punching bag'." Wall Street Journal May 15, 2006:A1. Accessed Aug 25, 2006, through Proquest database.
12. Bombardier C., Laine L., Reicin A., et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR study group. N Engl J Med 343 (2000) 1520-1528 2 p following 1528
13. Curfman G.D., Morrissey S., and Drazen J.M. Expression of concern: Bombardier et al, "comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.". N Engl J Med 353 (2005) 2813-2814
14. Bombardier C., Laine L., Burgos-Vargas R., et al. Response to expression of concern regarding VIGOR study. N Engl J Med 354 (2006) 1196-1199
15. Curfman G.D., Morrissey S., and Drazen J.M. Expression of concern reaffirmed. N Engl J Med 354 (2006) 1193
16. FDA announces plan to strengthen advisory committee processes. FDA News, July 24, 2006. Available at: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01416.html. Accessed August 25, 2006.